Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Innate immune double-stranded RNA (dsRNA) sensors are a specialized class of pattern recognition receptors (PRRs) that detect dsRNA, a key molecular signature of viral replication and cellular stress. This group comprises several distinct proteins, including the endosomal Toll-like receptor 3 (TLR3) and cytosolic sensors such as the RIG-I-like receptors (RIG-I and MDA5), protein kinase R (PKR), and 2'-5'-oligoadenylate synthetase (OAS). Upon binding to dsRNA, these sensors trigger signaling cascades—primarily through the adapter proteins TRIF or MAVS—that culminate in the production of type I interferons (IFNs) and pro-inflammatory cytokines, which orchestrate the host's antiviral defense and bridge innate and adaptive immunity. In therapeutic development, these sensors are primarily targeted by agonists, such as Rintatolimod and Poly-ICLC, to induce a "viral mimicry" state in cancer cells, thereby enhancing the efficacy of immunotherapies and promoting antitumor immune responses. Conversely, the aberrant activation of these sensors by endogenous "self" dsRNA is implicated in the pathogenesis of autoimmune and autoinflammatory disorders, such as Aicardi-Goutières syndrome, making them targets for inhibitory strategies. Therapeutic challenges include managing systemic inflammation and the risk of cytokine release syndrome associated with potent immune activation.
Agonism of pattern recognition receptors to induce type I interferon production and activate innate and adaptive immune responses.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Innate immune double-stranded RNA sensors (dsRNA sensors).